דילוג לניווט ראשי
דילוג לחיפוש
דילוג לתוכן הראשי
מיון לפי
Keyphrases
Anticoagulation
20%
Anticoagulation Quality
20%
Apixaban
20%
Bleeding Events
20%
Blood Products
20%
Cancer Patients
20%
Chemotherapy
20%
Descriptive Statistics
20%
First-line Chemotherapy
60%
Imaging Reports
20%
Increasing Risk
20%
Khorana
20%
Logistic Regression
20%
MDClone
20%
Medical Center
20%
Metastatic Cancer
20%
Multivariable
20%
Natural Language Processing
20%
Oral Anticoagulants
100%
Oral Anticoagulation
20%
Ovarian Cancer
100%
Ovarian Cancer Patients
40%
Patient Characteristics
20%
Product Consumption
20%
Program Implementation
60%
Prophylactic Anticoagulants
20%
Protective Factors
20%
Quality Improvement Intervention
20%
Quality Improvement Program
40%
Quality Improvement Project
100%
Risk Factors
20%
Risk Prediction
20%
Risk Reduction
20%
Risk Selection
20%
Risk Stratification
40%
SHEBA
20%
Staff Education
20%
Stratified Group
20%
Systemic Chemotherapy
20%
Thromboprophylaxis
20%
Treatment Lines
100%
Venous Thromboembolic Events
40%
Venous Thromboembolism
100%
Venous Thromboembolism Risk
20%
Working Diagnosis
20%
Medicine and Dentistry
Anticoagulant
12%
Anticoagulation
25%
Antithrombotic
100%
Apixaban
12%
Blood Product
12%
Chemotherapy
25%
Education
12%
First-Line Chemotherapy
37%
Language Processing
12%
Logistic Regression Analysis
12%
Metastatic Carcinoma
12%
Oral
12%
Ovarian Cancer
100%
Patient Characteristics
12%
Protective Factor
12%
Quality Improvement
100%
Risk Reduction
12%
Risk Stratification
12%
Thromboprophylaxis
12%
Venous Thromboembolism
100%
Nursing and Health Professions
Anticoagulant Agent
100%
Anticoagulation
25%
Apixaban
12%
Chemotherapy
62%
Imaging
12%
Logistic Regression Analysis
12%
Natural Language Processing
12%
Ovary Cancer
100%
Staff Training
12%
Total Quality Management
100%
Venous Thromboembolism
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Apixaban
12%
Chemotherapy Regimens
25%
First-Line Chemotherapy
37%
Ovary Cancer
100%
Venous Thromboembolism
100%